We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01312220
Recruitment Status : Unknown
Verified February 2011 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : March 10, 2011
Last Update Posted : March 10, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.

Condition or disease
the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver

Study Design

Study Type : Observational
Estimated Enrollment : 10 participants
Observational Model: Cohort
Official Title: Relationship of Serological Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
Study Start Date : February 2011
Estimated Study Completion Date : February 2013
Groups and Cohorts


Outcome Measures

Biospecimen Retention:   Samples With DNA
Serum Liver piece

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
acute liver failure who received liver transplantation
Criteria

Inclusion Criteria:

Acute liver failure Received iver transplantation

Exclusion Criteria:

Pregnancy Sepsis Heart failure

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01312220


Contacts
Contact: CM Ho, MD +88623123456 ext 65914 miningho@ntu.edu.tw

Locations
Taiwan
NTUH Recruiting
Taipei, Taiwan, 100
Contact: CM Ho, MD    +88623123456 ext 65914    miningho@ntu.edu.tw   
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: CM Ho, MD National Taiwan University Hospital
More Information

Responsible Party: CM Ho, NTUH
ClinicalTrials.gov Identifier: NCT01312220     History of Changes
Other Study ID Numbers: 201101061RC
First Posted: March 10, 2011    Key Record Dates
Last Update Posted: March 10, 2011
Last Verified: February 2011

Additional relevant MeSH terms:
Liver Failure
Liver Failure, Acute
Hepatic Insufficiency
Liver Diseases
Digestive System Diseases
Mitogens
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action